Want to see HK:9877 full AI Analyst Report?
Jenscare Scientific Co. Ltd. Class H (9877) Ratios
Jenscare Scientific Co. Ltd. Class H Ratios
HK:9877's free cash flow for Q2 2026 was $-90.11M. For the 2026 fiscal year, HK:9877's free cash flow was decreased by $-15.08M and operating cash flow was $-75.02M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.86 | 10.68 | 19.68 | 15.08 | 16.68 |
| Quick Ratio | 5.61 | 10.13 | 19.20 | 14.90 | 16.58 |
| Cash Ratio | 4.79 | 9.44 | 15.81 | 12.82 | 16.11 |
| Solvency Ratio | -2.03 | -0.00 | -3.60 | -7.42 | -9.79 |
| Operating Cash Flow Ratio | -0.71 | -3.39 | -3.79 | -2.79 | -2.86 |
| Short-Term Operating Cash Flow Coverage | -2.67 | -13.58 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 497.72M | $ 575.24M | $ 1.05B | $ 797.06M | $ 778.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.06 | 0.03 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.06 | 0.07 | 0.04 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.06 | 0.06 | 0.03 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.05 | 0.03 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.10 | 1.08 | 1.04 | 1.04 |
| Debt Service Coverage Ratio | -7.27 | -0.01 | 0.00 | -4453.25 | -3859.76 |
| Interest Coverage Ratio | -265.23 | -0.73 | 0.00 | -4524.58 | -3875.71 |
| Debt to Market Cap | 0.01 | 0.05 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.12 | 0.16 | 0.11 | 0.01 | 0.01 |
| Net Debt to EBITDA | 2.19 | 2680.56 | 2.06 | 1.43 | 1.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.47% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -253.85% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -237.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -253.85% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -301.04% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -299.41% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -301.04% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.46% | 95.52% | 98.06% | 99.64% | 99.97% |
| EBT Per EBIT | 118.59% | 88.15% | 86.46% | 86.24% | 99.37% |
| Return on Assets (ROA) | -29.47% | -0.02% | -28.01% | -30.69% | -37.31% |
| Return on Equity (ROE) | -33.45% | -0.02% | -30.15% | -31.99% | -38.78% |
| Return on Capital Employed (ROCE) | -28.33% | -0.02% | -34.57% | -37.19% | -39.01% |
| Return on Invested Capital (ROIC) | -27.29% | -0.02% | -34.52% | -37.00% | -38.97% |
| Return on Tangible Assets | -29.64% | -0.02% | -28.10% | -40.02% | -37.38% |
| Earnings Yield | -7.92% | -0.01% | -5.75% | -2.06% | -6.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.89 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 61.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 28.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 457.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 424.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 485.81 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.18 | -0.53 | -0.53 | -0.43 | -0.42 |
| Free Cash Flow Per Share | -0.19 | -0.71 | -0.72 | -0.57 | -0.46 |
| Dividend Paid and CapEx Coverage Ratio | -14.79 | -3.05 | -2.84 | -3.20 | -9.24 |
| Capital Expenditure Coverage Ratio | -14.79 | -3.05 | -2.84 | -3.20 | -9.24 |
| Operating Cash Flow Coverage Ratio | -1.58 | -3.38 | -5.05 | -40.94 | -58.88 |
| Operating Cash Flow to Sales Ratio | -0.85 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -2.40% | -23.21% | -4.65% | -0.98% | -2.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.49 | -7010.47 | -17.39 | -48.54 | -15.56 |
| Price-to-Sales (P/S) Ratio | 37.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.22 | 1.34 | 5.24 | 15.53 | 6.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -41.65 | -4.31 | -21.50 | -102.51 | -49.52 |
| Price-to-Operating Cash Flow Ratio | -44.46 | -5.72 | -29.06 | -134.57 | -54.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.26 | 135.64 | 0.67 | 2.57 | -0.41 |
| Enterprise Value Multiple | -13.70 | -3478.85 | -12.99 | -40.81 | -13.93 |
| Enterprise Value | 2.87B | 702.86M | 5.58B | 20.60B | 6.99B |
| EV to EBITDA | -13.70 | -3478.85 | -12.99 | -40.81 | -13.93 |
| EV to Sales | 32.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -35.90 | -2.43 | -18.56 | -99.03 | -44.44 |
| EV to Operating Cash Flow | -38.33 | -3.23 | -25.08 | -130.00 | -49.25 |
| Tangible Book Value Per Share | 1.84 | 2.23 | 2.93 | 2.85 | 3.81 |
| Shareholders’ Equity Per Share | 1.89 | 2.28 | 2.96 | 3.76 | 3.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.63 | -0.00 | -0.89 | -1.20 | -1.48 |
| Tax Burden | 0.99 | 0.96 | 0.98 | 1.00 | 1.00 |
| Interest Burden | 1.19 | 0.88 | 0.86 | 0.86 | 0.99 |
| Research & Development to Revenue | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.28 | 1.23 | 0.60 | 0.36 | 0.28 |
Currency in CNY
